Evidence map›Paper›PMID 32024651›Full record

ArticleAnnals of the rheumatic diseases2020

Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?

Paul Studenic, David Felson, Maarten de Wit, Farideh Alasti, Tanja A Stamm, Josef S Smolen, Daniel Aletaha

Open access · greenAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Management strategies in rheumatoid arthritis.Nature reviews. Rheumatology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Paul StudenicDepartment of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria.ORCID 0000-0002-8895-6941
David FelsonSection of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-2668-2447
Maarten de WitStanding Committee of People with Arthritis/Rheumatism in Europe (PARE), EULAR, Zurich, Switzerland.ORCID 0000-0002-8428-6354
Farideh AlastiDepartment of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria.
Tanja A StammCenter for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University of Vienna, Wien, Austria.ORCID 0000-0003-3073-7284
Josef S SmolenDepartment of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria.
Daniel AletahaDepartment of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria daniel.aletaha@meduniwien.ac.at.
Medical University of Vienna · ATBoston University · USEuropean League Against Rheumatism · CH

Funding

Research and Evaluation Support Core Unit (RESCU Core)P30AR072571 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Paul Lavalley · 2019 to 2026
$6.9M
NIAMS NIH HHS P30 AR072571
6 · The paper itself

Abstract

objectivesThis study aimed to evaluate different patient global assessment (PGA) cut-offs required in the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Boolean remission definition for their utility in rheumatoid arthritis (RA).

methodsWe used data from six randomised controlled trials in early and established RA. We increased the threshold for the 0-10 score for PGA gradually from 1 to 3 in steps of 0.5 (Boolean1.5 to Boolean3.0) and omitted PGA completely (BooleanX) at 6 and 12 months. Agreement with the index-based (Simplified Disease Activity Index (SDAI)) remission definition was analysed using kappa, recursive partitioning (classification and regression tree (CART)) and receiver operating characteristics. The impact of achieving each definition on functional and radiographic outcomes after 1 year was explored.

resultsData from 1680 patients with early RA and 920 patients with established RA were included. The proportion of patients achieving Boolean remission increased with higher thresholds for PGA from 12.4% to 19.7% in early and 5.9% to 12.3% in established RA at 6 months. Best agreement with SDAI remission occurred at PGA cut-offs of 1.5 and 2.0, while agreement decreased with higher PGA (CART: optimal agreement at PGA≤1.6 cm; sensitivity of PGA≤1.5 95%). Changing PGA thresholds at 6 months did not affect radiographic progression at 12 months (mean ꙙsmTSS for Boolean, 1.5, 2.0, 2.5, 3.0, BooleanX: 0.35±5.4, 0.38±5.14, 0.41±5.1, 0.37±4.9, 0.34±4.9, 0.27±4.7). However, the proportion attaining HAQ≤0.5 was 90.2%, 87.9%, 85.2%, 81.1%, 80.7% and 73.1% for the respective Boolean definitions.

conclusionIncreasing the PGA cut-off to 1.5 cm would provide high consistency between Boolean with the index-based remission; the integer cut-off of 2.0 cm performed similarly.

Indexed as

Outcome Assessment, Health CareAdalimumabAntibodies, MonoclonalArthritis, RheumatoidHumansInfliximabRandomized Controlled Trials as TopicRemission InductionSeverity of Illness IndexTumor Necrosis Factor InhibitorsVisual Analog ScaleAdalimumabAntibodies, MonoclonalgolimumabInfliximabTumor Necrosis Factor Inhibitorsdisease activityoutcomes researchpatient perspectiverheumatoid arthritis

Identifiers

PMID32024651
PMCPMC10564460
OpenAlexW3004695550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.